Position in MRK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,389,316
+$103,475 QoQ
Shares Held
26,376
-3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#1,269
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Patten Group, Inc. holds $22,707,053 across 8 Drug Manufacturers - General names. MRK ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,927 | $5,822,770 | |
| 2 | AZN |
Astrazeneca PLC
|
29,983 | $5,685,376 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
26,376 | $3,389,316 | |
| 4 | LLY |
ELI LILLY & Co
|
2,822 | $3,384,791 | |
| 5 | NVS |
Novartis AG
|
16,667 | $2,612,051 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,094 | $1,100,195 | |
| 7 | ABBV |
AbbVie Inc.
|
1,875 | $471,824 | |
| 8 | SNY |
Sanofi
|
5,643 | $240,730 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,389,316 | 26,376 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,285,841 | 27,316 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,870,124 | 27,267 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,499,771 | 29,784 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,447,073 | 30,913 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,762,184 | 30,773 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,021,903 | 30,377 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,036,140 | 26,736 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $3,106,265 | 25,091 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,307,194 | 25,064 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $2,745,450 | 25,183 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,670,420 | 25,939 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,024,833 | 26,214 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $2,788,907 | 26,214 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $2,827,338 | 25,483 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,086,343 | 24,226 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,206,769 | 24,205 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $1,996,194 | 24,329 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,876,070 | 24,479 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,091,588 | 27,847 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,350,287 | 30,221 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,402,048 | 31,159 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,576,289 | 31,495 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,282,702 | 27,519 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,027,516 | 26,219 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,895,723 | 24,639 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||